After discovering how some haematologic cancer cells manage to elude death from a targeted therapy, Dana-Farber Cancer Institute scientists have double-crossed the cancer cells with a drug that renders them vulnerable to the targeted agent. At the 59th...
Original Article: ASH 2017: Study identifies agent that can reverse resistance to targeted drug in some leukaemia
NEXT ARTICLE